Related Experiment Videos

Cardiovascular dysfunction in sepsis and critical illness

Barret J Bulmer1

  • 1Department of Clinical Sciences, Cummings School of Veterinary Medicine at Tufts University, 200 Westboro Road, North Grafton, MA 01536, USA. Barret.Bulmer@tufts.edu

The Veterinary Clinics of North America. Small Animal Practice
|July 16, 2011
PubMed

Insights

Myocardial dysfunction, common in sepsis and critical illness in dogs, increases mortality. Understanding its mechanisms and improving cardiac function management may reduce fatalities.

Area of Science:

  • Veterinary Medicine
  • Cardiology
  • Critical Care Medicine

Background:

  • Myocardial dysfunction is a frequent complication in human and canine sepsis and critical illness.
  • This cardiac impairment is associated with elevated mortality rates in affected individuals.
  • Effective management requires understanding the underlying disease processes and their impact on the heart.

Purpose of the Study:

  • To review clinical findings, pathophysiologic mechanisms, and current treatment considerations for myocardial dysfunction in critically ill dogs.
  • To highlight the need for further research into identifying and managing cardiac dysfunction in this population.

Main Methods:

  • This review synthesizes existing clinical findings and proposed pathophysiologic mechanisms.
  • It discusses current therapeutic strategies and considerations for myocardial dysfunction.
  • The review emphasizes the need for further research.

Main Results:

  • Myocardial dysfunction is a significant contributor to mortality in sepsis and critical illness.
  • Current understanding of pathophysiologic mechanisms is incomplete.
  • Practical methods for early identification and effective interventions are lacking.

Conclusions:

  • Mitigating the consequences of cardiac impairment requires a thorough understanding of myocardial dysfunction.
  • Further research is essential to develop reliable diagnostic tools and effective, mortality-reducing interventions.
  • Augmenting cardiac performance through timed interventions may reduce mortality in critically ill dogs.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...